Replies to post #324551 on Amarin Corp Plc (AMRN)

[north40000]

Perhaps true. The news re cohort 6 vis a vis cohort 12[Amarin's Vascepa added] in GILD's NASH trial has not been released as yet, among other indications driving revenue that GILD could find useful in its portfolio.